Comparison of Therapeutic Efficacy Between Intralesional Bleomycin and Cryotherapy in Plantar Warts
Primary Purpose
Viral Wart
Status
Completed
Phase
Not Applicable
Locations
Pakistan
Study Type
Interventional
Intervention
COMPARISON OF THERAPEUTIC EFFICACY BETWEEN INTRALESIONAL BLEOMYCIN AND CRYOTHERAPY IN PLANTAR WARTS
Sponsored by
About this trial
This is an interventional treatment trial for Viral Wart
Eligibility Criteria
Inclusion Criteria -healthy individuals of both genders between 18 to 50 years Exclusion Criteria Pregnant and Lactating women history of vascular diseases/ chilblains Immunocompromised patients Treated previously for warts
Sites / Locations
- Adeel Siddiqui
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
BLEOMYCIN
CRYOTHERAPY
Arm Description
COMPARISON OF THERAPEUTIC EFFICACY BETWEEN INTRALESIONAL BLEOMYCIN AND CRYOTHERAPY IN PLANTAR WARTS
COMPARISON OF THERAPEUTIC EFFICACY BETWEEN INTRALESIONAL BLEOMYCIN AND CRYOTHERAPY IN PLANTAR WARTS
Outcomes
Primary Outcome Measures
comparative effecacy of intra lesional bleomycin vs cryotherapy in treating plantar warts within 30 days of treatment
Intralesional bleomycin is more effective than cryotherapy in treating plantar warts within
Secondary Outcome Measures
Full Information
NCT ID
NCT05752435
First Posted
February 1, 2023
Last Updated
February 21, 2023
Sponsor
Combined Military Hospital Abbottabad
1. Study Identification
Unique Protocol Identification Number
NCT05752435
Brief Title
Comparison of Therapeutic Efficacy Between Intralesional Bleomycin and Cryotherapy in Plantar Warts
Official Title
Comparison of Therapeutic Efficacy Between Intralesional Bleomycin and Cryotherapy in Plantar Warts
Study Type
Interventional
2. Study Status
Record Verification Date
February 2023
Overall Recruitment Status
Completed
Study Start Date
July 1, 2022 (Actual)
Primary Completion Date
December 31, 2022 (Actual)
Study Completion Date
December 31, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Combined Military Hospital Abbottabad
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
A randomized control trial to compare the efficacy difference between intralesional bleomycin and cryotherapy in treating plantar warts.
Detailed Description
In spite of many available studies on bleomycin and cryotherapy in treating warts, little head-to-head research is carried out to compare the efficacy of these treatments. This study shows clear difference in the clearance of warts treated with intralesional bleomycin and cryotherapy.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Viral Wart
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized Control Trial (RCT)
Masking
Outcomes Assessor
Masking Description
cure
Allocation
Randomized
Enrollment
102 (Actual)
8. Arms, Groups, and Interventions
Arm Title
BLEOMYCIN
Arm Type
Active Comparator
Arm Description
COMPARISON OF THERAPEUTIC EFFICACY BETWEEN INTRALESIONAL BLEOMYCIN AND CRYOTHERAPY IN PLANTAR WARTS
Arm Title
CRYOTHERAPY
Arm Type
Active Comparator
Arm Description
COMPARISON OF THERAPEUTIC EFFICACY BETWEEN INTRALESIONAL BLEOMYCIN AND CRYOTHERAPY IN PLANTAR WARTS
Intervention Type
Procedure
Intervention Name(s)
COMPARISON OF THERAPEUTIC EFFICACY BETWEEN INTRALESIONAL BLEOMYCIN AND CRYOTHERAPY IN PLANTAR WARTS
Intervention Description
comparison of therapeutic efficacy between intralesional bleomycin and cryotherapy in plantar warts
Primary Outcome Measure Information:
Title
comparative effecacy of intra lesional bleomycin vs cryotherapy in treating plantar warts within 30 days of treatment
Description
Intralesional bleomycin is more effective than cryotherapy in treating plantar warts within
Time Frame
30 days of treatment
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria
-healthy individuals of both genders between 18 to 50 years
Exclusion Criteria
Pregnant and Lactating women
history of vascular diseases/ chilblains
Immunocompromised patients
Treated previously for warts
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Adeel Dr Siddiqui, FCPS
Organizational Affiliation
Combined Military Hospital Abbottabad
Official's Role
Study Director
Facility Information:
Facility Name
Adeel Siddiqui
City
ABbottabad
State/Province
KPK
Country
Pakistan
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
COMPARISON OF THERAPEUTIC EFFICACY BETWEEN INTRALESIONAL BLEOMYCIN AND CRYOTHERAPY IN PLANTAR WARTS
IPD Sharing Time Frame
COMPARISON OF THERAPEUTIC EFFICACY BETWEEN INTRALESIONAL BLEOMYCIN AND CRYOTHERAPY IN PLANTAR WARTS
IPD Sharing Access Criteria
via email
Learn more about this trial
Comparison of Therapeutic Efficacy Between Intralesional Bleomycin and Cryotherapy in Plantar Warts
We'll reach out to this number within 24 hrs